Cramer's lightning round: The analysts downgrading Edwards Lifesciences are 'knuckleheads'
January 09, 2018 at 18:47 PM EST
Jim Cramer flew through his take on callers' favorite stocks, including a biotechnology stock being targeted by Wall Street.
